ID   Hep-G2/SF
AC   CVCL_AS98
SY   Hep G2/SF; HepG2/SF; HepG2-SF; Hep-G2/Serum Free
DR   ATCC; HB-8065.1
DR   Wikidata; Q54882793
CC   Group: Serum/protein free medium cell line.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; 7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Discontinued: ATCC; HB-8065.1; true.
CC   Derived from sampling site: Liver.
ST   Source(s): ATCC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,13
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 20-05-21; Version: 11
//